DALLAS, May 25 /PRNewswire-FirstCall/ -- BioTech Medics, Inc., (OTC Pink Sheets: BTMD) announced today that they have made a presentation to doctors and staff at the Muenster Memorial Hospital in Texas with the intention to open a BioTech Medics Pain Management and Wellness Center Outpatient Clinic. "This will provide a convenient location for patients in North Texas and the Southern Oklahoma area to be treated. With the high cost of gasoline, this will save patients money from having to travel about 200 miles round trip to Dallas for treatment", said Keith Houser, CEO. "We are also in negotiations to open a BioTech Medics Pain Management & Wellness Center in Rockwall, Texas. Rockwall is one of the fastest growing communities in Texas," said Mr. Houser. "This will provide a more convenient center for those who live in East Texas." BioTech Medics is a distributor for the FDA cleared NeuroLase Therapeutic Medical Laser. The NeuroLase is one of the most powerful Class 3B therapeutic lasers in the USA which is for the temporary reduction or elimination of muscular, skeletal and arthritic pain without drugs or surgery. Medical practitioners seeking to provide drug-free pain management for their patients are encouraged to contact BioTech Medics. For more information contact: Keith Houser, CEO Phone 972-274-5533 On the web at: http://www.biotechmedics.com/ Safe Harbor for Forward-Looking Statements. This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward- looking statements. Such risks and uncertainties include, but are not limited to, the ability of the company to complete financing, market conditions, the general acceptance of the Company's products and technologies, timing, and other risks. DATASOURCE: BioTech Medics, Inc. CONTACT: Keith Houser, CEO of BioTech Medics, Inc., +1-972-274-5533 Web site: http://www.biotechmedics.com/

Copyright